Search results
Found 31107 matches for
Researchers have developed a vaccine that blocks the effects of the main cause of pain in osteoarthritis (OA) - nerve growth factor (NGF) - in mice.
©
Shutterstock
Clinical Kennedy Trust Prize Studentships
Applications for these projects close at noon on Friday 2 December 2025.
Botnar projects
Applications for these projects close at noon on Friday 2 December 2025.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Meet the Kennedy team
-
Tonia Vincent
Associate Director of the Kennedy Institute and the Kennedy Trust Maini Feldmann Professor of Translational Musculoskeletal Science
Read the paper
Active immunization targeting Nerve Growth Factor attenuates chronic pain behavior in murine osteoarthritis
Annals of Rheumatic Disease, 12 March 2019. doi: 10.1136/annrheumdis-2018-214489
In collaboration with
Supported by
